GSK shares rose to the top of the FTSE 100 leader board after the drugmaker raised its 2025 guidance on the back of a strong third-quarter performance. The earnings were the last to be presented by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback